SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-05-056718
Filing Date
2005-11-18
Accepted
2005-11-18 14:46:25
Documents
3
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-20568_110qa.htm 10-Q/A 35631
2 302 CERTIFICATION a05-20568_1ex31d1.htm EX-31.1 10199
3 302 CERTIFICATION a05-20568_1ex31d2.htm EX-31.2 9305
  Complete submission text file 0001104659-05-056718.txt   56624
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-30319 | Film No.: 051215012
SIC: 2834 Pharmaceutical Preparations